These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 8679271)

  • 21. Second Conference on Radioimmunodetection and Radioimmunotherapy of Cancer. Princeton, New Jersey, September 8-10, 1988. Proceedings.
    Cancer Res; 1990 Feb; 50(3 Suppl):774s-1059s. PubMed ID: 2297722
    [No Abstract]   [Full Text] [Related]  

  • 22. Pretargeting: taking an alternate route for localizing radionuclides.
    Sharkey RM; Chang CH; Rossi EA; McBride WJ; Goldenberg DM
    Tumour Biol; 2012 Jun; 33(3):591-600. PubMed ID: 22396041
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Monoclonal antibody therapy of cancer.
    Jurcic JG; Scheinberg DA; Houghton AN
    Cancer Chemother Biol Response Modif; 1997; 17():195-216. PubMed ID: 9551215
    [No Abstract]   [Full Text] [Related]  

  • 24. Problems and advances in the dosimetry of radionuclide targeted therapy.
    Humm JL
    Recent Results Cancer Res; 1996; 141():37-65. PubMed ID: 8722419
    [No Abstract]   [Full Text] [Related]  

  • 25. Phase I/II trial of (131)I-MN-14F(ab)2 anti-carcinoembryonic antigen monoclonal antibody in the treatment of patients with metastatic medullary thyroid carcinoma.
    Juweid ME; Hajjar G; Swayne LC; Sharkey RM; Suleiman S; Herskovic T; Pereira M; Rubin AD; Goldenberg DM
    Cancer; 1999 Apr; 85(8):1828-42. PubMed ID: 10223579
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of recombinant alpha-interferon on pharmacokinetics, biodistribution, toxicity, and efficacy of 131I-labeled monoclonal antibody CC49 in breast cancer: a phase II trial.
    Macey DJ; Grant EJ; Kasi L; Rosenblum MG; Zhang HZ; Katz RL; Rieger PT; LeBherz D; South M; Greiner JW; Schlom J; Podoloff DA; Murray JL
    Clin Cancer Res; 1997 Sep; 3(9):1547-55. PubMed ID: 9815842
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The use of epidermal growth factor receptor-425 monoclonal antibodies radiolabeled with iodine-125 in the adjuvant treatment of patients with high grade gliomas of the brain.
    Miyamoto CT; Brady LW; Rackover MA; Emrich J; Class R; Bender H; Micaily B; Steplewski Z
    Recent Results Cancer Res; 1996; 141():183-92. PubMed ID: 8722428
    [No Abstract]   [Full Text] [Related]  

  • 28. High dose radioimmunotherapy in malignant lymphoma.
    Eary JF; Press OW
    Recent Results Cancer Res; 1996; 141():177-82. PubMed ID: 8722427
    [No Abstract]   [Full Text] [Related]  

  • 29. Biological and clinical perspectives of cancer imaging and therapy with radiolabeled antibodies.
    Goldenberg DM; Blumenthal RD; Sharkey RM
    Semin Cancer Biol; 1990 Jun; 1(3):217-25. PubMed ID: 2103497
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Radioimmunotherapy: a specific treatment protocol for cancer by cytotoxic radioisotopes conjugated to antibodies.
    Kawashima H
    ScientificWorldJournal; 2014; 2014():492061. PubMed ID: 25379535
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Development of a streptavidin-anti-carcinoembryonic antigen antibody, radiolabeled biotin pretargeting method for radioimmunotherapy of colorectal cancer. Studies in a human colon cancer xenograft model.
    Sharkey RM; Karacay H; Griffiths GL; Behr TM; Blumenthal RD; Mattes MJ; Hansen HJ; Goldenberg DM
    Bioconjug Chem; 1997; 8(4):595-604. PubMed ID: 9258460
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Use of monoclonal antibodies for the diagnosis and treatment of bladder cancer.
    Syrigos KN; Deonarian DP; Epenetos AA
    Hybridoma; 1999 Jun; 18(3):219-24. PubMed ID: 10475235
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Can preirradiation enhance tumor uptake of radiolabeled pharmaceuticals? Experimental data in a mouse neuroblastoma xenograft system.
    Sautter-Bihl ML; Bihl H
    Recent Results Cancer Res; 1996; 141():123-35. PubMed ID: 8722423
    [No Abstract]   [Full Text] [Related]  

  • 34. Radiation dosimetry results and safety correlations from 90Y-ibritumomab tiuxetan radioimmunotherapy for relapsed or refractory non-Hodgkin's lymphoma: combined data from 4 clinical trials.
    Wiseman GA; Kornmehl E; Leigh B; Erwin WD; Podoloff DA; Spies S; Sparks RB; Stabin MG; Witzig T; White CA
    J Nucl Med; 2003 Mar; 44(3):465-74. PubMed ID: 12621016
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Computational models of antibody-based tumor imaging and treatment protocols.
    Praxmarer M; Sung C; Bungay PM; van Osdol WW
    Ann Biomed Eng; 2001 Apr; 29(4):340-58. PubMed ID: 11339331
    [TBL] [Abstract][Full Text] [Related]  

  • 36. New insights into the pretargeting approach to image and treat tumours.
    Patra M; Zarschler K; Pietzsch HJ; Stephan H; Gasser G
    Chem Soc Rev; 2016 Nov; 45(23):6415-6431. PubMed ID: 27722526
    [TBL] [Abstract][Full Text] [Related]  

  • 37. High-dose radioimmunotherapy combined with extracorporeal depletion in a syngeneic rat tumor model: evaluation of toxicity, therapeutic effect, and tumor model.
    Mårtensson L; Nilsson R; Ohlsson T; Sjögren HO; Strand SE; Tennvall J
    Cancer; 2010 Feb; 116(4 Suppl):1043-52. PubMed ID: 20127949
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Optimal therapeutic strategies for radioimmunotherapy.
    O'Donoghue JA
    Recent Results Cancer Res; 1996; 141():77-99. PubMed ID: 8722421
    [No Abstract]   [Full Text] [Related]  

  • 39. A phase II study of [90Y] yttrium-capromab pendetide in the treatment of men with prostate cancer recurrence following radical prostatectomy.
    Kahn D; Austin JC; Maguire RT; Miller SJ; Gerstbrein J; Williams RD
    Cancer Biother Radiopharm; 1999 Apr; 14(2):99-111. PubMed ID: 10850293
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Factors influencing the pharmacokinetics, dosimetry, and diagnostic accuracy of radioimmunodetection and radioimmunotherapy of carcinoembryonic antigen-expressing tumors.
    Behr TM; Sharkey RM; Juweid MI; Dunn RM; Ying Z; Zhang CH; Siegel JA; Gold DV; Goldenberg DM
    Cancer Res; 1996 Apr; 56(8):1805-16. PubMed ID: 8620497
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.